[Leish-l] Publication of Article collection - Immunity against Leishmaniasis: host defences, immunotherapy and vaccines

Sat Oct 22 10:19:50 BRST 2016

Dear Herbert,Many thanksAli 

    On Friday, October 21, 2016 3:33 PM, "egalati at usp.br" <egalati at usp.br> wrote:

 #yiv9322315558 p {margin:0;}Dear HerbertThank you very much for sending me these articles. They will be very useful for me and my students.Sincerely,Eunice A B Galati

De: herbert at biof.ufrj.br
Para: "Leish-L" <leish-l at lineu.icb.usp.br>
Enviadas: Sábado, 8 de Outubro de 2016 22:59:26
Assunto: [Leish-l] Publication of Article collection - Immunity against Leishmaniasis: host defences, immunotherapy and vaccines

Dear colleagues.

I would like to announce the publication of article collection  
entitled Immunity against Leishmaniasis: host defences, immunotherapy  
and vaccines. See below all manuscripts.

I would like to thank you so much for all colleagues that participate  
in this collection. Thank you so much!

Thank you so much Prof. Jeffrey for share this collection with me.

Hope to have opportunity to work together in the future

Best regards, Herbert

  Herbert Leonel de Matos Guedes
Professor, Ph.D.
Lecturer of Immunology and Parasitology
Leader the group of Immunology and Vaccinology
Institute of Biophysics Carlos Chagas Filho
Federal University of Rio de Janeiro

Immunity against Leishmaniasis: host defences, immunotherapy and vaccines

http://www.biomedcentral.com/collections/leishmania

Leishmaniasis is a serious public health problem in both tropical and  
temperate regions, caused by protozoan parasites of the genus  
Leishmania. Over 20 Leishmania species as well as hybrids are involved  
and they are transmitted to humans by the bite of infected  
phlebotomine female sandflies. It is principally a zoonotic disease  
and some 70 animal species are reservoirs but, in some regions,humans  
themselves are the source of infection. 1.3 million new cases and 20  
000 deaths occur annually.

There are 3 main clinical forms:
• Cutaneous: the most common form, 95% of the cases occur in the  
Americas, the Mediterranean basin, the Middle East and Central Asia -  
single or disseminated skin lesions
• Mucocutaneous: principally in the Americas, destruction of mucosal  
regions of the nose, mouth and throat
• Visceral: the fatal form of disease, the majority of cases occur in  
6 countries: Bangladesh, Brazil, Ethiopia, India, Sudan and South Sudan.

There are two other important, but less common, forms:
• Diffuse cutaneous leishmaniasis (DCL): an anergid form of disease -  
rare, America and Oriental Africa
• Post-kala-azar dermal leishmaniasis (PKDL): endemic in East Africa  
and the Indian subcontinent. A sequela of visceral resolution, there  
is cutaneous manifestation.

There is a lack of sustainable control measures and different forms of  
the disease are expanding. Of particular concern is the increasing  
number of subclinical infections of Leishmania parasites that may  
flare up due to immunosuppression or be a source of infection in blood  
transfusions or organ transplants. A key goal is the reduction of  
fatal cases of visceral leishmaniasis in both India and Brazil but  
this is difficult in the absence of a vaccine for humans. Treatment in  
lower-income countries is based on toxic medicines developed in the  
1940s. This is aggravated by the development of resistance to these  
older medications.

The aim of this collectio is to draw attention to areas of basic and  
applied research that focus on immunity/pathogenesis in the  
development of new therapies and vaccines.

Guest Editors: Prof. Jeffrey Shaw and Prof. Herbert Leonel de Matos Guedes

     18) Research
     Efficacy of intranasal LaAg vaccine against Leishmania  
amazonensis infection in partially resistant C57Bl/6 mice

     Juliana Elena Silveira Pratti, Tadeu Diniz Ramos, Joyce Carvalho  
Pereira, Alessandra Marcia da Fonseca-Martins, Diogo Maciel-Oliveira,  
Gabriel Oliveira-Silva, Mirian França de Mello, Suzana Passos Chaves,  
Daniel Claudio Oliveira Gomes, Bruno Lourenço Diaz, Bartira  
Rossi-Bergmann and Herbert Leonel de Matos Guedes

     Parasites & Vectors 2016 9:534

     17) Review
     Differences in immune responses against Leishmania induced by  
infection and by immunization with killed parasite antigen:  
implications for vaccine discovery

     Sergio C. F. Mendonça

     Parasites & Vectors 2016 9:492

     16) Review
     Crosstalk between purinergic receptors and lipid mediators in  
leishmaniasis

     Mariana M. Chaves, Cláudio Canetti and Robson Coutinho-Silva

     Parasites & Vectors 2016 9:489

     15) Research
     Multicomponent LBSap vaccine displays immunological and  
parasitological profiles similar to those of Leish-Tec® and Leishmune®  
vaccines against visceral leishmaniasis

    Ludmila Zanandreis de Mendonça, Lucilene Aparecida Resende,  
Mariana Ferreira Lanna, Rodrigo Dian de Oliveira Aguiar-Soares, Bruno  
Mendes Roatt, Renata Alves de Oliveira e Castro, Maurício Azevedo  
Batista, Denise Silveira-Lemos, Juliana de Assis Silva Gomes, Ricardo  
Toshio Fujiwara, Simone Aparecida Rezende, Olindo Assis Martins-Filho,  
Rodrigo Corrêa-Oliveira, Walderez Ornelas Dutra, Alexandre Barbosa  
Reis and Rodolfo Cordeiro Giunchetti

     Parasites & Vectors 2016 9:472

     14) Review
     The immunology of post-kala-azar dermal leishmaniasis (PKDL)

     Eduard E. Zijlstra

     Parasites & Vectors 2016 9:464

     13) Research
     The leishmanicidal activity of oleuropein is selectively  
regulated through inflammation- and oxidative stress-related genes

     Ioannis D. Kyriazis, Olga S. Koutsoni, Nektarios Aligiannis,  
Kalliopi Karampetsou, Alexios-Leandros Skaltsounis and Eleni Dotsika

     Parasites & Vectors 2016 9:441

     12) Letter to the Editor
     Comment on “Regulation of immunity during visceral Leishmania  
infection” and further discussions about the role of antibodies in  
infections with Leishmania

     Luiz Gustavo Gardinassi and Isabel Kinney Ferreira de Miranda Santos

     Parasites & Vectors 2016 9:386

     11) Research
     Development of real-time PCR assays for evaluation of immune  
response and parasite load in golden hamster (Mesocricetus auratus)  
infected by Leishmania (Viannia) braziliensis

     Raquel Peralva Ribeiro-Romão, Andrea Franco Saavedra, Alda Maria  
Da-Cruz, Eduardo Fonseca Pinto and Otacilio C. Moreira

     Parasites & Vectors 2016 9:361

     10) Research
     Insulin-like growth factor-I serum levels and their biological  
effects on Leishmania isolates from different clinical forms of  
American tegumentary leishmaniasis

    Luana Dias de Souza, Célia Maria Vieira Vendrame, Amélia Ribeiro  
de Jesus, Márcia Dias Teixeira Carvalho, Andréa Santos Magalhães,  
Albert Schriefer, Luiz Henrique Guimarães, Edgar Marcelino de Carvalho  
and Hiro Goto

     Parasites & Vectors 2016 9:335

     9) Review
     Possibilities and challenges for developing a successful vaccine  
for leishmaniasis

    Saumya Srivastava, Prem Shankar, Jyotsna Mishra and Sarman Singh

     Parasites & Vectors 2016 9:277

     8) Review
     The site of the bite: Leishmania interaction with macrophages,  
neutrophils and the extracellular matrix in the dermis

     Juliana Perrone de Menezes, Elvira M. Saraiva and Bruno da Rocha-Azevedo

     Parasites & Vectors 2016 9:264

     7) Research
     Application of rapid in vitro co-culture system of macrophages  
and T-cell subsets to assess the immunogenicity of dogs vaccinated  
with live attenuated Leishmania donovani centrin deleted parasites  
(LdCen−/−)

     Kelvinson Fernandes Viana, Jacqueline Araújo Fiuza, Sreenivas  
Gannavaram, Ranadhir Dey, Angamuthu Selvapandiyan, Daniella  
Castanheira Bartholomeu, Denise da Silveira-Lemos, Lilian Lacerda  
Bueno, Walderez Ornelas Dutra, Ricardo Toshio Fujiwara, Hira L.  
Nakhasi and Rodolfo Cordeiro Giunchetti

     Parasites & Vectors 2016 9:250

     6) Research
     The sandfly Lutzomyia longipalpis LL5 embryonic cell line has  
active Toll and Imd pathways and shows immune responses to bacteria,  
yeast and Leishmania

     Bruno Tinoco-Nunes, Erich Loza Telleria, Monique da Silva-Neves,  
Christiane Marques, Daisy Aline Azevedo-Brito, André Nóbrega Pitaluga  
and Yara Maria Traub-Csekö

     Parasites & Vectors 2016 9:222

     5) Research
     Impact of reactive oxygen species (ROS) on the control of  
parasite loads and inflammation in Leishmania amazonensis infection

     Eric Henrique Roma, Juan Pereira Macedo, Grazielle Ribeiro Goes,  
Juliana Lauar Gonçalves, Waldionê de Castro, Daniel Cisalpino and Leda  
Quercia Vieira

     Parasites & Vectors 2016 9:193

     4) Short report
     Imipramine alters the sterol profile in Leishmania amazonensis  
and increases its sensitivity to miconazole

    Valter Viana Andrade-Neto, Thaís Martins Pereira, Marilene do  
Canto-Cavalheiro and Eduardo Caio Torres-Santos

     Parasites & Vectors 2016 9:183

     3) Research
     Clinical, hematological and biochemical alterations in hamster  
(Mesocricetus auratus) experimentally infected with Leishmania  
infantum through different routes of inoculation

     Nádia das Dores Moreira, Juliana Vitoriano-Souza, Bruno Mendes  
Roatt, Paula Melo de Abreu Vieira, Wendel Coura-Vital, Jamille Mirelle  
de Oliveira Cardoso, Mariana Trevisan Rezende, Henrique Gama Ker,  
Rodolfo Cordeiro Giunchetti, Claudia Martins Carneiro and Alexandre  
Barbosa Reis

     Parasites & Vectors 2016 9:181

     2) Review
     Study of Leishmania pathogenesis in mice: experimental considerations

    Corinne Loeuillet, Anne-Laure Bañuls and Mallorie Hide

     Parasites & Vectors 2016 9:144

     1) Review
     Regulation of immunity during visceral Leishmania infection

     Vasco Rodrigues, Anabela Cordeiro-da-Silva, Mireille Laforge,  
Ricardo Silvestre and Jérôme Estaquier

     Parasites & Vectors 2016 9:118

_______________________________________________
Leish-l mailing list
Leish-l at lineu.icb.usp.br
http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l

--
This email was sent by icb.usp.br

--
 This email was sent by icb.usp.br     
_______________________________________________
Leish-l mailing list
Leish-l at lineu.icb.usp.br
http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l

--
This email was sent by icb.usp.br

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lineu.icb.usp.br/pipermail/leish-l/attachments/20161022/c8723978/attachment-0001.htm>